NCT04958174 is a clinical trial of web-application in Development, Child, sponsored by Weprom.

Who is sponsoring NCT04958174?

NCT04958174 is sponsored by Weprom.

What drugs are being tested in NCT04958174?

Interventions in NCT04958174: web-application.

What condition does NCT04958174 study?

NCT04958174 studies Development, Child.

Is NCT04958174 still recruiting?

NCT04958174 is currently status unknown. Last updated 20 December 2021.

Last reviewed 2021-12-20 · How we verify

NCT04958174

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Smartphone Application for Screening of Developmental Disorders in Children

Status unknown Last updated 20 December 2021

What this trial tests

trial testing web-application in Development, Child in 180 participants. Status unknown.

Timeline

15 August 2021

Primary endpoint
15 February 2023

15 February 2023

Quick facts

Lead sponsor	Weprom
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	180
Start date	15 August 2021
Primary completion	15 February 2023
Estimated completion	15 February 2023
Sites	1 location across France

Drugs / interventions tested

web-application

Conditions studied

Development, Child — all drugs for Development, Child →

Sponsor

Weprom — full company profile →

Who can join

Adults 1 Month to 3, any sex, with Development, Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The detection of developmental disorders in the child is often late because the parents do not have the information necessary to consult at the first clinical signs. For example, the diagnosis of autism spectrum disorders is made at the age of 5, so earlier diagnoses are possible earlier or even in the 1st year with appropriate questionnaires. An application (Malo) has been developed to allow through regular questionnaires from 1 month to 3 years old to assess the child's development by his parents in the form of a digital health record assessing several areas at regular intervals (monthly the 1st year then every 3 to 12 months): sensory, psychomotor development, sleep, height and weight, cognitive and addictions (especially to screens). The questions will be adapted to the age of the child. An alert suggesting to consult the general practitioner or the pediatrician will be generated according to an algorithm validated by a committee of experts. Based on a study model on health data already carried out as part of the triage application for patients suspected of COVID 19 coronavirus disease.fr with 14 million users in 6 months having improved the relevance of calls to the 15 (8 times fewer unnecessary calls) and general practitioners. This study will assess parental interest in this application.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Early Detection of Neurodevelopmental Disorders of Toddlers and Postnatal Depression by Mobile Health App: Observational Cross-sectional Study.
Denis F, Maurier L, Carillo K, Ologeanu-Taddei R, et al · · 2022 · cited 7× · PMID 35576565 · DOI 10.2196/38181

Verify or expand the search:

Other trials of web-application

Trials testing the same drug.

NCT05215028 — Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study · completed

Other recruiting trials for Development, Child

Currently open trials in the same condition.

NCT05912270 — Orchestra in Class, a Novel Booster for Executive Functions and Brain Development in Young Primary School Children · NA · recruiting
NCT05916144 — The Effect of Interaction-Based Early Education Program Applied to Grandparents on the Grandchildren's Health · NA · active not recruiting
NCT05834907 — Hands and Hearts Together · NA · recruiting
NCT05665049 — Social Transfers for Exclusive Breastfeeding · NA · active not recruiting
NCT04785352 — Grandi Byen: Test of an Integrated Parenting and Nutrition Intervention · NA · active not recruiting

Other Weprom trials

Trials by the same sponsor.

NCT05298293 — Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma · NA · not yet recruiting
NCT06301087 — Early Detection Neurodevelopmental Disorders of Children and Prevention of Postnatal Depression by Mobile Health App · completed
NCT05215028 — Optimization of Mother-child Dyad Follow-up by a Multidomain Application: Real-world Cross Sectional Study · completed
NCT04764487 — A Web-mediated Follow-up With the Web-application KidneyPRO Versus Standard Follow-up for Patients With Advanced Renal C · Phase 3 · unknown
NCT04806880 — Study Evaluating the Olfactory Recovery of Anosmia Post COVID-19 by Olfactory Rehabilitation Assisted by Web-application · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04958174 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Weprom
Last refreshed: 20 December 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04958174.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing